South San Francisco
67°F | 51°F
South San Francisco Local Business
Local business in South San Francisco, CA
-
22 hrs ago | via SFGate
Canada trying to lure Silicon Valley tech workers
The Canadian government has launched an aggressive campaign to lure Silicon Valley tech workers frustrated by U.S. visa policies northward, just as Congress wrestles with a long-sought overhaul of America's immigration system. Comment?
-
Yesterday | via The Campbell Reporter
Canada comes to Silicon Valley to poach high-tech wo...
Canada has landed in Silicon Valley with a brazen message: Give us your smart, your restless, your huddled Googleplex workers yearning to breathe life into the high-tech economy up north. Comment?
-
Wednesday | via SFBG Politics Blog
Can the tech boom solve our housing crisis? No, but ...
San Francisco Housing Action Coalition and San Francisco Magazine posed an intriguing question at a forum they sponsored last night in the W Hotel: "San Francisco's Housing Crisis: Can the Tech Boom Help Us?" Unfortunately, it wasn't a question they ever really addressed at an event of, by, and for developers and their most ardent supporters. Comment?
-
Tuesday May 14 | via Freshnews
FDA Approves Tarceva (Erlotinib) Tablets and Cobas E...
SOUTH SAN FRANCISCO, Calif. & NORTHBROOK, Ill. -- -- Genentech, a member of the Roche Group and Astellas Pharma US, Inc. Comment?
-
Monday May 13 | via Potrero View
CleanPowerSF Unpopular with Both Sides of the Politi...
CleanPowerSF which will launch later this year or early next will offer San Franciscans up to 30 megawatts of renewable power purchased from Shell Energy North America. Comment?
-
Monday May 13 | via Erie Times News
News to share around the water cooler
The Food and Drug Administration says it has approved a new once-a-day inhaler drug from GlaxoSmithKline for patients with chronic lung disease. Comment?
-
Monday May 13 | via The Wichita Eagle
Elan enters $1B royalty deal with Theravance
Irish drugmaker Elan Corp. PLC plans to pay $1 billion for the right to future royalties from four respiratory treatments being developed by Theravance Inc. Comment?
-
Monday May 13 | via Milwaukee Journal-Sentinal
Artificial kidney offers hope to patients tethered t...
Shuvo Roy, associate professor of bioengineering and therapeutic sciences, holds a dialysis cartridge while talking about creating ways to eliminate the need for dialysis by creating an artificial kidney at the University of California, San Francisco. Comment?
-
Monday May 13 | via The Washington Post
Elan to Pay $1 Billion for Stake in Theravance's Roy...
Elan Corp. agreed to pay $1 billion for a share of the royalties on new drugs from Theravance Inc. Comment?
-
Monday May 13 | via Curbed
Hidden Histories: Hidden in the Bayview Was the Bay ...
Welcome to Curbed's ongoing series titled Hidden History , where Curbed highlights a Bay Area location with a secret past. Comment?
-
Monday May 13 | via Local Tech Wire
Elan to pay $1B for a share of Theravance's royaltie...
Elan Corp. agreed to pay $1 billion for a share of the royalties on new drugs from Theravance Inc. Comment?
-
Monday May 13 | via BioSpace
Elan Corporation PLC Bets $1 Billion on Theravance, ...
Elan Corporation PLC Bets $1 Billion on Theravance, Inc. Drugs; Move to Spurn Its Hostile Suitor? Theravance Stock Up +40.16 5.22 @ 10:12 AM ET Staying up-to-date has never been simpler. Comment?
-
Monday May 13 | via The Washington Post
Elan to Pay $1 Billion for Stake in Theravance's Gla...
Elan Corp., the Irish drugmaker facing a takeover offer by Royalty Pharma, agreed to pay $1 billion for a share of the royalties on new drugs that Theravance Inc. Comment?
-
Sunday May 12 | via Business Wire
Theravance and Elan Enter Into a $1.0 Billion Royalt...
SOUTH SAN FRANCISCO, Calif. & DUBLIN-- --Theravance, Inc. and Elan Corporation, plc today announced that they have entered into a royalty participation agreement wherein Elan will purchase a participation interest in potential future royalty payments related to four respiratory programs partnered with GlaxoSmithKline plc : RELVARa ELLIPTAa /BREOa ... (more) Comment?
-
Saturday May 11 | via CHOW
Philz: San Francisco's Next Big-Time Coffee Chain?
Breaking news in SF's coffee wars: Philz Coffee , started in 2003 by Phil Jaber, recently raised in the neighborhood of $15 million in venture capital to expand the business. Comment?
-
Friday May 10 | via Vallejo News
FDA approves once-a-day inhaler from Glaxo The Food ...
The Food and Drug Administration says it has approved a new once-a-day inhaler drug from GlaxoSmithKline for patients with chronic lung disease. Comment?
-
Friday May 10 | via Curbed
Then & Now: What Was Once a Bar is Now a KFC/Tac...
Public spaces change fast here in San Francisco, and for better or worse, it can be pretty crazy when you see what the City used to look like. Comment?
-
Friday May 10 | via PhysOrg Weblog
FDA approves once-a-day inhaler from Glaxo
The Food and Drug Administration says it has approved a new once-a-day inhaler drug from GlaxoSmithKline for patients with chronic lung disease. Comment?
-
Friday May 10 | via WUSA9
FDA Approves 1-A-Day Inhaler For Chronic Lung Disease
The Food and Drug Administration says it has approved a new once-a-day inhaler drug from GlaxoSmithKline for patients with chronic lung disease. Comment?
-
Friday May 10 | via BioSpace
Millennium Pharmaceuticals, Inc. (South San Francisc...
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Deborah Dunsire, the CEO who led Millennium Pharmaceuticals to prominence in cancer treatment, is leaving the company in an abrupt departure five years after it was acquired by Japan-based Takeda Pharmaceuticals. Comment?
Copyright ©2013 Topix LLC